27898362|t|Psychogenic non-epileptic seizure in patients with intellectual disability with special focus on choice of therapeutic intervention
27898362|a|There have been a number of studies exploring treatments for psychogenic non-epileptic seizure (PNES) but largely neglecting the sizable subgroup of patients with intellectual disability (ID). In the present study, we attempted to demonstrate effects and preferred modes of therapeutic intervention in PNES patients with ID being treated at a Japanese municipal center with a short referral chain. We examined 46 PNES patients with ID (ID group) and 106 PNES patients without ID (non-ID group) retrospectively in case charts. In addition to examining basic demographic and clinical data, effects of different therapeutic intervention were examined as a function of decrease or disappearance of PNES attacks in the ID group. Age at the first visit as well as PNES onset was younger in the ID than in the non-ID group (t=2.651, p=0.009; t=3.528, p=0.001, respectively). PNES -free ratio at the last visit tended to be higher in the non-ID group (chi square =3.455; p=0.063). Psychosis was more often encountered in the ID group (chi square =13.443; p=0.001). Although cognitive therapy and pharmaco-therapeutic approaches were quite similarly distributed in both groups, environmental adjustment was often introduced in the ID group (44%) as compared to the non-ID group (15%) (chi square =14.299; p=0.001). Brief weekly visit service is also more often utilized by the patients with ID (54%) than by those without ID (35%) (chi square =5.021, p=0.025). Optimal treatment approaches in this sizable patient subgroup should be the subject of future prospective studies.
27898362	0	33	Psychogenic non-epileptic seizure	T048	C1142430
27898362	37	45	patients	T101	C0030705
27898362	51	74	intellectual disability	T048	C3714756
27898362	97	103	choice	T052	C1707391
27898362	107	131	therapeutic intervention	T061	C0808232
27898362	160	167	studies	T062	C2603343
27898362	178	188	treatments	T061	C0087111
27898362	193	226	psychogenic non-epileptic seizure	T048	C1142430
27898362	228	232	PNES	T048	C1142430
27898362	246	256	neglecting	T033	C0243095
27898362	269	277	subgroup	T185	C1515021
27898362	281	289	patients	T101	C0030705
27898362	295	318	intellectual disability	T048	C3714756
27898362	320	322	ID	T048	C3714756
27898362	332	339	present	T079	C0521116
27898362	340	345	study	T062	C2603343
27898362	350	359	attempted	T051	C1516084
27898362	363	374	demonstrate	T169	C0205319
27898362	375	382	effects	T080	C1704420
27898362	387	396	preferred	T078	C0558295
27898362	406	430	therapeutic intervention	T061	C0808232
27898362	434	438	PNES	T048	C1142430
27898362	439	447	patients	T101	C0030705
27898362	453	455	ID	T048	C3714756
27898362	462	469	treated	T169	C1522326
27898362	475	500	Japanese municipal center	T093	C1708333
27898362	508	513	short	T081	C1806781
27898362	514	528	referral chain	T058	C0034927
27898362	533	541	examined	T033	C0332128
27898362	545	549	PNES	T048	C1142430
27898362	550	558	patients	T101	C0030705
27898362	564	566	ID	T048	C3714756
27898362	568	570	ID	T048	C3714756
27898362	571	576	group	T078	C0441833
27898362	586	590	PNES	T048	C1142430
27898362	591	599	patients	T101	C0030705
27898362	608	610	ID	T048	C3714756
27898362	612	618	non-ID	T033	C0243095
27898362	619	624	group	T078	C0441833
27898362	626	641	retrospectively	T080	C1514923
27898362	645	656	case charts	T170	C3842891
27898362	658	672	In addition to	T169	C0332287
27898362	673	682	examining	T033	C0332128
27898362	689	700	demographic	T090	C0011298
27898362	705	718	clinical data	T170	C1516606
27898362	720	730	effects of	T080	C1704420
27898362	731	740	different	T080	C1705242
27898362	741	765	therapeutic intervention	T061	C0808232
27898362	771	779	examined	T033	C0332128
27898362	785	793	function	T169	C0542341
27898362	797	805	decrease	T081	C0547047
27898362	809	822	disappearance	T079	C2746065
27898362	826	830	PNES	T048	C1142430
27898362	846	848	ID	T048	C3714756
27898362	849	854	group	T078	C0441833
27898362	856	859	Age	T032	C0001779
27898362	873	878	visit	T058	C1512346
27898362	890	894	PNES	T048	C1142430
27898362	895	900	onset	T080	C0332162
27898362	905	912	younger	T079	C0332239
27898362	920	922	ID	T048	C3714756
27898362	935	941	non-ID	T033	C0243095
27898362	942	947	group	T078	C0441833
27898362	1000	1004	PNES	T048	C1142430
27898362	1011	1016	ratio	T081	C0456603
27898362	1029	1034	visit	T058	C1512346
27898362	1048	1054	higher	T080	C0205250
27898362	1062	1068	non-ID	T033	C0243095
27898362	1069	1074	group	T078	C0441833
27898362	1069	1074	group	T078	C0441833
27898362	1076	1086	chi square	T081	C1552646
27898362	1105	1114	Psychosis	T048	C0033975
27898362	1149	1151	ID	T048	C3714756
27898362	1152	1157	group	T078	C0441833
27898362	1159	1169	chi square	T081	C1552646
27898362	1198	1215	cognitive therapy	T061	C0009244
27898362	1220	1240	pharmaco-therapeutic	T061	C0013216
27898362	1263	1272	similarly	T080	C2348205
27898362	1273	1284	distributed	T169	C1704711
27898362	1293	1299	groups	T078	C0441833
27898362	1301	1314	environmental	T082	C0014406
27898362	1315	1325	adjustment	T169	C0456081
27898362	1336	1346	introduced	T169	C1292748
27898362	1354	1356	ID	T048	C3714756
27898362	1357	1362	group	T078	C0441833
27898362	1372	1380	compared	T052	C1707455
27898362	1388	1394	non-ID	T033	C0243095
27898362	1395	1400	group	T078	C0441833
27898362	1408	1418	chi square	T081	C1552646
27898362	1438	1443	Brief	T079	C1879313
27898362	1444	1450	weekly	T079	C0332174
27898362	1451	1464	visit service	T058	C1512346
27898362	1484	1492	utilized	T169	C0042153
27898362	1500	1508	patients	T101	C0030705
27898362	1514	1516	ID	T048	C3714756
27898362	1545	1547	ID	T048	C3714756
27898362	1555	1565	chi square	T081	C1552646
27898362	1584	1591	Optimal	T080	C2698651
27898362	1592	1601	treatment	T061	C0087111
27898362	1629	1636	patient	T101	C0030705
27898362	1637	1645	subgroup	T185	C1515021
27898362	1660	1667	subject	T078	C1706203
27898362	1671	1677	future	T079	C0016884
27898362	1678	1697	prospective studies	T062	C0033522